DAI Xiao Chang 戴晓畅

Dr. DAI Xiao Chang

  • Sirnaomics Executive Director / Scientific and Strategic Director

Dr. Dai Xiaochang has over 20 years of experience in biotech technology. Prior to joining Sirnaomics, Dr. Dai served as the chairman of Yunnan Walvax Biopharmaceutical Co., Ltd., the predecessor of Walvax Biotechnology Co., Ltd. a company listed on Shenzhen Stock Exchange, the managing director of Kunming Baker Norton Pharmaceutical Co., Ltd. in 2005, and the president of Kunyao Group Co., Ltd. a company listed on Shanghai Stock Exchange.

Dr. Dai participates in the formulation of the general corporate business plans, strategies and major decisions of Sirnaomics through the Board. Dr. Dai currently serves as a professor at the School of Chemical Science and Engineering, Yunnan University since 2000, the executive director of Value Measure Investments Limited since January 2011 and the executive director of Trinity Power Limited since March 2012, respectively. Dr. Dai also serves as a director of Shenzhen Yunda Technology Industry Co., Ltd. since August 2001.

Dr. Dai obtained a master’s degree in biochemistry in Shanghai Institute of Biochemistry, Chinese Academy of Sciences in the PRC. During this period, he and his team developed the sixth type of plant hormone, “Yunda-120”. They later became a widely used plant growth regulator. Dr. Dai finished his doctoral degree in chemistry from The Scripps Research Institute in San Diego, California, U.S., and he also conducted postdoctoral research in the laboratory of John N. Ablelson, Division of Biology and Biological Engineering, California Institute of Technology in the U.S. from November 1998 to December 1999. At that time, his main research project was the development of nucleases for biotherapeutic use using in vitro evolutionary techniques.